URL
https://clinicaltrials.gov/study/NCT07222215?term=CAPELA&rank=1

Dana-Farber/ Harvard Cancer Center, Georgetown University, MD Anderson Cancer Center, University of California San Francisco, University of Chicago Medical Center, University of North Carolina at Chapel Hill, University of Pennsylvania, University of Pittsburgh, Vanderbilt University, Yale University

Long title
Phase II Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)